AstraZeneca PLC Ordinary Shares (AZN)

Total Current Liabilities

$31.52B

Quarterly · Period ending: · USD

AZN logo

AZN Total Current Liabilities

Latest reported$31.52B
AZN Quarterly Current Liabilities ($3.49B → $31.52B)
High-resolution chart · PNG

AZN total current liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

AstraZeneca PLC Ordinary Shares Total Current Liabilities — Quarterly (USD)
Period endingTotal Current Liabilities (USD)
31,516,152,000
32,570,000,000
30,617,000,000
34,054,000,000
33,536,000,000
29,129,000,000
27,866,000,000
25,926,000,000
28,566,000,000
28,901,000,000
30,542,000,000
28,588,000,000
26,375,000,000
24,860,000,000
26,293,000,000
24,850,000,000
21,815,000,000
22,740,000,000
22,594,000,000
23,649,000,000
22,222,000,000
21,513,000,000
20,307,000,000
18,942,000,000
18,183,000,000
17,043,000,000
18,117,000,000
14,776,000,000
16,034,000,000
18,256,000,000
16,292,000,000
15,248,000,000
17,201,000,000
18,164,000,000
16,383,000,000
14,463,000,000
15,657,000,000
15,429,000,000
15,256,000,000
15,382,000,000
14,335,000,000
15,932,000,000
14,869,000,000
16,036,000,000
16,150,000,000
15,758,000,000
17,330,000,000
15,824,000,000
16,322,000,000
17,513,000,000
16,051,000,000
14,675,000,000
15,197,000,000
13,862,000,000
13,903,000,000
14,128,000,000
14,801,000,000
15,800,000,000
15,752,000,000
14,657,000,000
13,838,000,000
16,016,000,000
16,787,000,000
16,852,000,000
16,304,000,000
16,994,000,000
17,640,000,000
15,116,000,000
15,143,000,000
14,049,000,000
13,320,000,000
14,456,000,000
15,991,000,000
15,682,000,000
15,187,000,000
15,528,000,000
24,933,000,000
10,349,000,000
9,447,000,000
8,088,000,000
8,405,000,000
9,447,000,000
6,839,000,000
6,741,000,000
6,797,000,000
6,839,000,000
7,782,000,000
6,760,000,000
6,957,000,000
7,747,000,000
7,695,000,000
7,095,000,000
7,121,789,715
8,159,427,793
8,215,000,000
6,900,802,680
7,162,602,097
7,231,195,048
9,268,517,559
6,404,091,926
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.